Literature DB >> 17393462

The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model.

Ivona Aksentijevich1, Christopher D Putnam2, Hal M Hoffman2, Daniel L Kastner1, Elaine F Remmers1, James L Mueller2, Julie Le1, Richard D Kolodner2, Zachary Moak1, Michael Chuang1, Frances Austin1, Raphaela Goldbach-Mansky1.   

Abstract

OBJECTIVE: The cryopyrinopathies are a group of rare autoinflammatory disorders that are caused by mutations in CIAS1, encoding the cryopyrin protein. However, cryopyrin mutations are found only in 50% of patients with clinically diagnosed cryopyrinopathies. This study was undertaken to investigate the structural effect of disease-causing mutations on cryopyrin, in order to gain better understanding of the impact of disease-associated mutations on protein function.
METHODS: We tested for CIAS1 mutations in 22 patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome, 12 with Muckle-Wells syndrome (MWS), 18 with familial cold-induced autoinflammatory syndrome (FCAS), and 3 probands with MWS/FCAS. In a subset of mutation-negative patients, we screened for mutations in proteins that are either homologous to cryopyrin or involved in the caspase 1/interleukin-1beta signaling pathway. CIAS1 and other candidate genes were sequenced, models of cryopyrin domains were constructed using structurally homologous proteins as templates, and disease-causing mutations were mapped.
RESULTS: Forty patients were mutation positive, and 7 novel mutations, V262A, C259W, L264F, V351L, F443L, F523C, and Y563N, were found in 9 patients. No mutations in any candidate genes were identified. Most mutations mapped to an inner surface of the hexameric ring in the cryopyrin model, consistent with the hypothesis that the mutations disrupt a closed form of cryopyrin, thus potentiating inflammasome assembly. Disease-causing mutations correlated with disease severity only for a subset of known mutations.
CONCLUSION: Our modeling provides insight into potential molecular mechanisms by which cryopyrin mutations can inappropriately activate an inflammatory response. A significant number of patients who are clinically diagnosed as having cryopyrinopathies do not have identifiable disease-associated mutations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393462      PMCID: PMC4321998          DOI: 10.1002/art.22491

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  52 in total

1.  The PSIPRED protein structure prediction server.

Authors:  L J McGuffin; K Bryson; D T Jones
Journal:  Bioinformatics       Date:  2000-04       Impact factor: 6.937

2.  Cascaded multiple classifiers for secondary structure prediction.

Authors:  M Ouali; R D King
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

3.  Structure and mechanism of the RuvB Holliday junction branch migration motor.

Authors:  C D Putnam; S B Clancy; H Tsuruta; S Gonzalez; J G Wetmur; J A Tainer
Journal:  J Mol Biol       Date:  2001-08-10       Impact factor: 5.469

4.  Response to anakinra in a de novo case of neonatal-onset multisystem inflammatory disease.

Authors:  Philip N Hawkins; Alison Bybee; Ebun Aganna; Michael F McDermott
Journal:  Arthritis Rheum       Date:  2004-08

5.  Successful treatment of acute visual loss in Muckle-Wells syndrome with interleukin 1 receptor antagonist.

Authors:  T Alexander; O Klotz; E Feist; K Rüther; G-R Burmester; U Pleyer
Journal:  Ann Rheum Dis       Date:  2005-08       Impact factor: 19.103

6.  Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome.

Authors:  Megumu Saito; Akihiro Fujisawa; Ryuta Nishikomori; Naotomo Kambe; Mami Nakata-Hizume; Momoko Yoshimoto; Katsuyuki Ohmori; Ikuo Okafuji; Takakazu Yoshioka; Takashi Kusunoki; Yoshiki Miyachi; Toshio Heike; Tatsutoshi Nakahata
Journal:  Arthritis Rheum       Date:  2005-11

Review 7.  Familial autoinflammatory diseases: genetics, pathogenesis and treatment.

Authors:  Silvia Stojanov; Daniel L Kastner
Journal:  Curr Opin Rheumatol       Date:  2005-09       Impact factor: 5.006

8.  Periodic fever, mild arthralgias, and reversible moderate and severe organ inflammation associated with the V198M mutation in the CIAS1 gene in three German patients--expanding phenotype of CIAS1 related autoinflammatory syndrome.

Authors:  Gönke Pörksen; Peter Lohse; Angela Rösen-Wolff; Stefan Heyden; Theresa Förster; Jörg Wendisch; Georg Heubner; Horst Bernuth; Svea Sallmann; Manfred Gahr; Joachim Roesler
Journal:  Eur J Haematol       Date:  2004-08       Impact factor: 2.997

9.  Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats.

Authors:  B Kobe; J Deisenhofer
Journal:  Nature       Date:  1993 Dec 23-30       Impact factor: 49.962

10.  Fine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353P.

Authors:  Hal M Hoffman; Simon G Gregory; James L Mueller; Mark Tresierras; David H Broide; Alan A Wanderer; Richard D Kolodner
Journal:  Hum Genet       Date:  2002-11-16       Impact factor: 4.132

View more
  134 in total

Review 1.  Inflammasome-mediated autoinflammatory disorders.

Authors:  Shruti P Wilson; Suzanne L Cassel
Journal:  Postgrad Med       Date:  2010-09       Impact factor: 3.840

2.  β-Glucan-induced reprogramming of human macrophages inhibits NLRP3 inflammasome activation in cryopyrinopathies.

Authors:  Giorgio Camilli; Mathieu Bohm; Alícia Corbellini Piffer; Rachel Lavenir; David L Williams; Benedicte Neven; Gilles Grateau; Sophie Georgin-Lavialle; Jessica Quintin
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

3.  Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations.

Authors:  Neda Ahmadi; Carmen C Brewer; Christopher Zalewski; Kelly A King; John A Butman; Nicole Plass; Cailin Henderson; Raphaela Goldbach-Mansky; H Jeffrey Kim
Journal:  Otolaryngol Head Neck Surg       Date:  2011-08       Impact factor: 3.497

4.  Coexistent MEFV and CIAS1 mutations manifesting as familial Mediterranean fever plus deafness.

Authors:  Davinder Singh-Grewal; Jeffrey Chaitow; Ivona Aksentijevich; John Christodoulou
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

Review 5.  Recurrent febrile syndromes: what a rheumatologist needs to know.

Authors:  Hal M Hoffman; Anna Simon
Journal:  Nat Rev Rheumatol       Date:  2009-05       Impact factor: 20.543

6.  A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome.

Authors:  Raphaela Goldbach-Mansky; Sharukh D Shroff; Mildred Wilson; Christopher Snyder; Sara Plehn; Beverly Barham; Tuyet-Hang Pham; Frank Pucino; Robert A Wesley; Joanne H Papadopoulos; Steven P Weinstein; Scott J Mellis; Daniel L Kastner
Journal:  Arthritis Rheum       Date:  2008-08

7.  Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS).

Authors:  M H Haverkamp; E van de Vosse; R Goldbach-Mansky; S M Holland
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

8.  The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity.

Authors:  Sangjun Park; Christine Juliana; Sujeong Hong; Pinaki Datta; Inhwa Hwang; Teresa Fernandes-Alnemri; Je-Wook Yu; Emad S Alnemri
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

Review 9.  Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses.

Authors:  Raphaela Goldbach-Mansky; Daniel L Kastner
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 10.  New insights into the epigenetics of inflammatory rheumatic diseases.

Authors:  Esteban Ballestar; Tianlu Li
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.